Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
4.250
+0.030 (0.71%)
At close: Feb 12, 2026, 4:00 PM EST
4.240
-0.010 (-0.24%)
After-hours: Feb 12, 2026, 4:10 PM EST
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $98.78 million as of February 12, 2026. Its market cap has decreased by -45.56% in one year.
Market Cap
98.78M
Enterprise Value
79.88M
1-Year Change
-45.56%
Ranking
Category
Stock Price
$4.25
Market Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has decreased from $152.13M to $98.78M, a decrease of -35.06%. That is a compound annual growth rate of -25.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 98.09M | -31.05% |
| Dec 31, 2025 | 142.25M | -8.50% |
| Dec 31, 2024 | 155.47M | 2.20% |
| Aug 13, 2024 | 152.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vivani Medical | 103.01M |
| Seer, Inc. | 101.82M |
| Agenus | 101.34M |
| Anixa Biosciences | 99.47M |
| Cassava Sciences | 99.03M |
| NovaBay Pharmaceuticals | 94.79M |
| Dogwood Therapeutics | 94.64M |
| Cognition Therapeutics | 94.45M |